Literature DB >> 17286659

Sample size and statistical power in the small-animal analgesia literature.

E H Hofmeister1, J King, M R Read, S C Budsberg.   

Abstract

OBJECTIVE: To document the power and required sample sizes to achieve certain treatment objectives in the veterinary analgesia literature.
METHODS: Pubmed's MEDLINE database and selected journals were searched. Only publications produced between 1994 and 2004 that reported 'no difference' between experimental groups in the abstract, results or conclusion sections and those that were randomised, prospective and blinded were reviewed. The data reported in the publications were then subjected to power analyses to determine the power and necessary sample size (to achieve a power of 0.8) to allow detection of 20 per cent, 50 per cent and 80 per cent treatment effects.
RESULTS: Twenty-two studies provided sufficient data for analysis. Five out of 22 (23 per cent) had sufficient power to detect a 20 per cent treatment effect, 12 of 22 (54 per cent) had sufficient power to detect a 50 per cent treatment effect and 18 of 22 (82 per cent) had sufficient power to detect an 80 per cent treatment effect. The mean number of animals required per group to document a 20 per cent, 50 per cent and 80 per cent treatment effect were 90, 15 and 7, respectively. CLINICAL SIGNIFICANCE: Publications that report no significant difference between analgesic regimens may have committed a Type II error. The reader may inappropriately conclude that there is no difference between treatments when there may, in fact, be a superior analgesic regimen. Clinical practice based on the principles of evidence-based medicine could therefore result in suboptimal care for patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17286659     DOI: 10.1111/j.1748-5827.2006.00234.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  5 in total

Review 1.  The challenges of assessing osteoarthritis and postoperative pain in dogs.

Authors:  Michele Sharkey
Journal:  AAPS J       Date:  2013-03-02       Impact factor: 4.009

2.  Development of a canine nociceptive thermal escape model.

Authors:  Kirsten Wegner; Kjersti A Horais; Nicolle A Tozier; Michael L Rathbun; Yuri Shtaerman; Tony L Yaksh
Journal:  J Neurosci Methods       Date:  2007-09-29       Impact factor: 2.390

3.  The effect of BIM deletion polymorphism on intrinsic resistance and clinical outcome of cancer patient with kinase inhibitor therapy.

Authors:  Hou-Qun Ying; Jie Chen; Bang-Shun He; Yu-Qin Pan; Feng Wang; Qi-Wen Deng; Hui-Ling Sun; Xian Liu; Shu-Kui Wang
Journal:  Sci Rep       Date:  2015-06-15       Impact factor: 4.379

4.  Efficacy, chondrotoxicity and plasma concentrations of tramadol following intra-articular administration in horses undergoing arthroscopy: preliminary findings.

Authors:  Alessandra Di Salvo; Elisabetta Chiaradia; Giorgia Della Rocca; Mario Giorgi; Francesco Mancini; Maria Luisa Marenzoni; Maria Beatrice Conti; Sara Nannarone
Journal:  Vet Q       Date:  2018-12       Impact factor: 3.320

5.  The Effect of the Canine ABCB1-1Δ Mutation on Sedation after Intravenous Administration of Acepromazine.

Authors:  D Deshpande; K E Hill; K L Mealey; J P Chambers; M A Gieseg
Journal:  J Vet Intern Med       Date:  2016-01-29       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.